Network features and pathway analyses of a signal transduction cascade

Frontiers in Neuroinformatics

Volumn 3, Issue MAY, 2009, Pages

  Yanashima, Ryoji ^a   Kitagawa, Noriyuki ^a   Matsubara, Yoshiya ^a   Weatheritt, Robert ^b   Oka, Kotaro ^a   Kikuchi, Shinichi ^a   Tomita, Masaru ^a   Ishizaki, Shun ^a  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Alzheimer's disease; Graph theory; Hippocampal CA1; K shortest path analysis; Network analysis; Network robustness; Python; Signal transduction

Indexed keywords

EID: 84861875417     PISSN: 16625196     EISSN: None     Source Type: Journal    
DOI: 10.3389/neuro.11.013.2009     Document Type: Article

References (52)

1. Allison, D. W., Chervin, A. S., Gelfand, V. I., and Craig, A. M. (2000). Postsynaptic scaffolds of excitatory and inhibitory synapses in hippocampal neurons: maintenance of core components independent of actin filaments and microtubules. J. Neurosci. 20, 4545-4554.
2. Bairoch, A., Boeckmann, B., Ferro, S., and Gasteiger, E. (2004). Swiss-Prot: juggling between evolution and stability. Brief. Bioinform. 5, 39-55.
3. Barrett, C. L., Price, N. D., and Palsson, B. O. (2006). Network-level analysis of metabolic regulation in the human red blood cell using random sampling and singular value decomposition. BMC Bioinformatics 7, 132.
4. Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., and Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23.
5. Blalock, E. M., Geddes, J. W., Chen, K. C., Porter, N. M., Markesbery, W. R., and Landfield, P. W. (2004). Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. U.S.A. 101, 2173-2178.
6. Borgwardt, K., and Kriegel, H. (2005). Shortest-Path Kernels on Graphs. Data mining. IEEE Int. Conf. Data Mining 50, 74-81.
7. Botella-Lopez, A., Burgaya, F., Gavin, R., Garcia-Ayllon, M. S., Gomez- Tortosa, E., Pena-Casanova, J., Urena, J. M., Del Rio, J. A., Blesa, R., Soriano, E., and Saez-Valero, J. (2006). Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103, 5573-5578.
8. Cacquevel, M., Lebeurrier, N., Cheenne, S., and Vivien, D. (2004). Cytokines in neuroinfl ammation and Alzheimer's disease. Curr. Drug Targets. 5, 529-534.
9. Chen, Z., McGee, M., Liu, Q., and Scheuermann, R. H. (2007). A distribution free summarization method for Affymetrix GeneChip arrays. Bioinformatics 23, 321-327.
10. Chuang, H. Y., Lee, E., Liu, Y. T., Lee, D., and Ideker, T. (2007). Network-based classifi cation of breast cancer metastasis. Mol. Syst. Biol. 3, 140.
11. Cole, G. M., and Frautschy, S. A. (2007). The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease. Exp. Gerontol. 42, 10-21.
12. Coulson, E. J. (2006). Does the p75 neurotrophin receptor mediate Abetainduced toxicity in Alzheimer's disease? J. Neurochem. 98, 654-660.
13. Dickson, B. J. (2002). Molecular mechanisms of axon guidance. Science 298, 1959-1964.
14. Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., and Stratton, M. R. (2004). A census of human cancer genes. Nat. Rev. Cancer 4, 177-183.
15. Gautier, L., Cope, L., Bolstad, B. M., Irizarry, R.A. (2004). affy - Analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307-315.
16. Groth, R. D., and Mermelstein, P. G. (2003). Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: a role for the transcription factor NFATc4 in neurotrophinmediated gene expression. J. Neurosci. 23, 8125-8134.
17. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
18. Harigaya, Y., Shoji, M., Shirao, T., and Hirai, S. (1996). Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J. Neurosci. Res. 43, 87-92.
19. Hayashi, Y., Shi, S. H., Esteban, J. A., Piccini, A., Poncer, J. C., and Malinow, R. (2000). Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287, 2262-2267.
20. Heneka, M. T., and O'Banion, M. K. (2007). Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184, 69-91.
21. Hoshi, M., Takashima, A., Murayama, M., Yasutake, K., Yoshida, N., Ishiguro, K., Hoshino, T., Imahori, K. (1997). Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease. J. Biol. Chem. 272, 2038-2041.
22. Ideker, T., and Sharan, R. (2008). Protein networks in disease. Genome Res. 18, 644-652.
23. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H. J., Hama, E., Sekine-Aizawa, Y., Saido, T. C. (2000). Identification of the major Abeta1-42- degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150.
24. Jeffery, I. B., Higgins, D. G., and Culhane, A. C. (2006). Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics 7, 359.
25. Jellinger, K. A. (2006). Challenges in neuronal apoptosis. Curr. Alzheimer Res. 3, 377-391.
26. Jeong, H., Tombor, B., Albert, R., Oltvai, Z. N., and Barabasi, A. L. (2000). The large-scale organization of metabolic networks. Nature 407, 651-654.
27. Korf, R. E. (1987). Depth-fi rst iterativedeepening. Artif. Intell. 27, 97-109.
28. Laske, C., Stransky, E., Leyhe, T., Eschweiler, G. W., Wittorf, A., Richartz, E., Bartels, M., Buchkremer, G., and Schott, K. (2006). Stage-dependent BDNF serum concentrations in Alzheimer's disease. J. Neural Transm. 113, 1217-1224.
29. Li, H. L., Wang, H. H., Liu, S. J., Deng, Y. Q., Zhang, Y. J., Tian, Q., Wang, X. C., Chen, X. Q., Yang, Y., Zhang, J. Y., Wang, Q., Xu, H., Liao, F. F., and Wang, J. Z. (2007). Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 104, 3591-3596.
30. Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Walker, D. G., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., Hulette, C., Schmechel, D., Alexander, G. E., Reiman, E. M., Rogers, J., and Stephan, D. A. (2007). Gene expression profi les in anatomically and functionally distinct regions of the normal aged human brain. Physiol. Genomics 28, 311-322.
31. Luscombe, N. M., Babu, M. M., Yu, H., Snyder, M., Teichmann, S. A., Gerstein, M. (2004). Genomic analysis of regulatory network dynamics reveals large topological changes. Nature 431, 308-312.
32. Ma, X., Lee, H., Wang, L., and Sun, F. (2007). CGI: a new approach for prioritizing genes by combining gene expression and protein-protein interaction data. Bioinformatics 23, 215-221.
33. Ma'ayan, A., Jenkins, S. L., Neves, S., Hasseldine, A., Grace, E., Dubin- Thaler, B., Eungdamrong, N. J., Weng, G., Ram, P. T., Rice, J. J., Kershenbaum, A., Stolovitzky, G. A., Blitzer, R. D., and Iyengar, R. (2005). Formation of regulatory patterns during signal propagation in a mammalian cellular network. Science 309, 1078-1083.
34. Maglott, D., Ostell, J., Pruitt, K. D., and Tatusova, T. (2007). Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 35, D26-D31.
35. Mason, O., Verwoerd, M. (2007). Graph theory and networks in Biology. IET. Syst. Biol. 1, 89-119.
36. McCusker, S. M., Curran, M. D., Dynan, K. B., McCullagh, C. D., Urquhart, D. D., Middleton, D., Patterson, C. C., McIlroy, S. P., and Passmore, A. P. (2001). Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 357, 436-439.
37. Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D., and Alon, U. (2002). Network motifs: simple building blocks of complex networks. Science 298, 824-827.
38. Nochomovitz, Y. D., and Li, H. (2006). Highly designable phenotypes and mutational buffers emerge from a systematic mapping between network topology and dynamic output. Proc. Natl. Acad. Sci. U.S.A. 103, 4180-4185.
39. Rahman, S. A., and Schomburg, D. (2006). Observing local and global properties of metabolic pathways: 'load points' and 'choke points' in the metabolic networks. Bioinformatics 22, 1767-1774.
40. Ravasz, E., Somera, A. L., Mongru, D. A., Oltvai, Z. N., and Barabasi, A. L. (2002). Hierarchical organization of modularity in metabolic networks. Science 297, 1551-1555.
41. Reimers, M., and Carey, V. J. (2006). Bioconductor: an open source framework for bioinformatics and computational biology. Methods Enzymol. 411, 119-134.
42. Serge, A., Fourgeaud, L., Hemar, A., and Choquet, D. (2003). Active surface transport of metabotropic glutamate receptors through binding to microtubules and actin fl ow. J. Cell Sci. 116, 5015-5022.
43. Shen-Orr, S. S., Milo, R., Mangan, S., and Alon, U. (2002). Network motifs in the transcriptional regulation network of Escherichia coli. Nat. Genet. 31, 64-68.
44. Smyth, G. K. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 1027-1053.
45. Su, J. H., Kesslak, J. P., Head, E., and Cotman, C. W. (2002). Caspasecleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta Neuropathol. 104, 1-6.
46. Tang, Y., Yamada, K., Kanou, Y., Miyazaki, T., Xiong, X., Kambe, F., Murata, Y., Seo, H., and Nabeshima, T. (2000). Spatiotemporal expression of BDNF in the hippocampus induced by the continuous intracerebroventricular infusion of beta-amyloid in rats. Brain Res. Mol. Brain Res. 80, 188-197.
47. Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P. U. H. S., Bakay, R., Patel, P., Blesch, A., Vahlsing, H. L., Ho, G., Tong, G., Potkin, S. G., Fallon, J., Hansen, L., Mufson, E. J., Kordower, J. H., Gall, C., and Conner, J. (2005). A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11, 551-555.
48. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
49. Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., DeStrooper, B., Saftig, P., Birchmeier, C., and Haass, C. (2006). Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314, 664-666.
50. Wuchty, S. (2001). Scale-free behavior in protein domain networks. Mol. Biol. Evol. 18, 1694-1702.
51. Yoon, S., Choi, J., Haam, J., Choe, H., and Kim, D. (2007). Reduction of mint- 1, mint-2, and APP overexpression in okadaic acid-treated neurons. Neuroreport 18, 1879-1883.
52. Zhang, Y. W., Wang, R., Liu, Q., Zhang, H., Liao, F. F., and Xu, H. (2007). Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression. Proc. Natl. Acad. Sci. U.S.A. 104, 10613-10618.